Development and In Vitro Assessment of a Pluronic-coconut Oil-lecithin Organogel for Topical Delivery of Lornoxicam in Managing Cervical Spondylosis

Yeshna; Monika Singh; Monika; Ankit Bansal; Samrat Chauhan; Rohit Dutt; Vikas Jhawat

doi:10.2174/0122103031378179250702115249

image of Development and In Vitro Assessment of a Pluronic-coconut Oil-lecithin Organogel for Topical Delivery of Lornoxicam in Managing Cervical Spondylosis

Development and In Vitro Assessment of a Pluronic-coconut Oil-lecithin Organogel for Topical Delivery of Lornoxicam in Managing Cervical Spondylosis
Authors: Yeshna¹, Monika Singh¹, Monika¹, Ankit Bansal², Samrat Chauhan², Rohit Dutt³ and Vikas Jhawat¹
View Affiliations Hide Affiliations

¹ Department of Pharmaceutical Science, School of Healthcare and Allied Science, GD Goenka University, Gurugram, Haryana, India; ² Department of Pharmacy, Chitkara University, Rajpura, Punjab, India; ³ Department of Chemistry, GMN College, Ambala Cantt., Haryana, India
Source: Drug Delivery Letters
Available online: 11 July 2025
DOI: https://doi.org/10.2174/0122103031378179250702115249
- Received: 01 Jan 2025
- Accepted: 22 Apr 2025
- Available online: 11 Jul 2025

Abstract

Introduction

Topical delivery via organogels offers a promising method to deliver Lornoxicam directly to the target site with improved bioavailability, avoiding the issues associated with systemic administration.

Methods

In this study, lecithin organogels containing Lornoxicam were developed using the microemulsion technique. First, pure soya lecithin was dispersed in coconut oil, which acted as both the dispersant and emulsifier, at room temperature to form the oily phase. By the following day, the lecithin had wholly dissolved in the mixture. Sorbic acid was added as a preservative. At the same time, Pluronic F-127 was mixed with cold water to form the aqueous phase. Lornoxicam, the active ingredient, was dissolved in polyethylene glycol-400 and combined with the lecithin-coconut oil mixture. The aqueous phase was slowly added to the oily phase while stirring with a homogenizer at 10,000 rpm.

Results

The formulated lornoxicam organogel was assessed based on its physical appearance, organoleptic properties such as appearance, color, homogeneity, consistency and texture. Developed formulations were also evaluated for viscosity, spreadability, pH, drug content, and in vitro release characteristics. Formulations F3 and F6 were selected for kinetic studies due to their satisfactory physical properties and maximum drug release.

Conclusion

The transdermal organogel formulation of Lornoxicam was an effective method for topical drug delivery. When applied to the skin, it showed anti-inflammatory and anti-rheumatic effects, making it a viable option for targeted drug delivery for cervical spondylosis.

Article metrics loading...

/content/journals/ddl/10.2174/0122103031378179250702115249

2025-07-11

2025-08-13

From This Site

/content/journals/ddl/10.2174/0122103031378179250702115249

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

References

Bentley M.V.L.B. Marchetti J.M. Ricardo N. Ali-Abi Z. Collett J.H. Influence of lecithin on some physical chemical properties of poloxamer gels: Rheological, microscopic and in vitro permeation studies. Int. J. Pharm. 1999 193 1 49 55 10.1016/S0378‑5173(99)00313‑0 10581421
[Google Scholar]
Bhatia A. Singh B. Amarji B. Katare O.P. Tamoxifen-loaded liposomal topical formulation arrests hair growth in mice. Br. J. Dermatol. 2010 163 2 412 415 10.1111/j.1365‑2133.2010.09772.x 20331445
[Google Scholar]
Couffin-Hoarau A.C. Motulsky A. Delmas P. Leroux J.C. In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives. Pharm. Res. 2004 21 3 454 457 10.1023/B:PHAM.0000019299.01265.05 15070096
[Google Scholar]
Dhandhi S. Development and characterization of a gallic acid-infused topical emulgel for enhanced wound management: Formulation and in vitro optimization. RSC Pharma. 2024 2 2 333 341 10.1039/d4pm00297k
[Google Scholar]
Gupta M. Goyal A.K. Paliwal S.R. Paliwal R. Mishra N. Vaidya B. Dube D. Jain S.K. Vyas S.P. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J. Liposome Res. 2010 20 4 341 350 10.3109/08982101003596125 20163329
[Google Scholar]
Jatav M.P. Ramteke S. Formulation and evaluation of lecithin organogel for treatment of arthritis. Inter. J. Scient. World 2015 3 2 267 274 10.14419/ijsw.v3i2.5028
[Google Scholar]
Jhawat V. Gupta S. Saini V. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid. Drug Deliv. 2016 23 9 3573 3581 10.1080/10717544.2016.1212439 27494650
[Google Scholar]
Kuo D.T. Tadi P. Cervical spondylosis. StatPearls Treasure Island, FL StatPearls Publishing 2023
[Google Scholar]
Lv Y. Tian W. Chen D. Liu Y. Wang L. Duan F. The prevalence and associated factors of symptomatic cervical Spondylosis in Chinese adults: A community-based cross-sectional study. BMC Musculoskelet. Disord. 2018 19 1 325 10.1186/s12891‑018‑2234‑0 30205836
[Google Scholar]
Mullin J. Shedid D. Benzel E. Overview of cervical spondylosis pathophysiology and biomechanics. World Spin. Col. J. 2011 2 3 89 97
[Google Scholar]
Nasseri A.A. Aboofazeli R. Zia H. Needham T.E. Lecithin-stabilized microemulsion. I: Phase behavior studies. Iran. J. Pharm. Res. 2003 2 1 59 61
[Google Scholar]
Nemutlu E. Demircan S. Kir S. Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods. Pharmazie 2005 60 6 421 425 15997830
[Google Scholar]
Nour S. A. Shalaby S. H. Afify N. N. Abd El-Aal S. Formulation and evaluation of econazole nitrate emulgels. J. Drug Res. Egypt 2002 24 1–2 63 71
[Google Scholar]
Soliman S.M. Abdel Malak N.S. El-Gazayerly O.N. Abdel Rehim A.A. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: in vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov. Ther. 2010 4 6 459 471 22491312
[Google Scholar]
Trivedi R. Samrit S. Amgaokar Y. Supe U. Umekar M. Wadher K. Formulation and evaluation of pluronic-lecithin organogel containing natural moisturizing agent for xerosis. J. Drug Deliv. Ther. 2022 12 5 170 174 10.22270/jddt.v12i5.5614
[Google Scholar]
Yadav A. Jhawat V. Singh R.P. Chauhan S. Dutt R. Goyal R. Singh D. Development and in vitro assessment of topical microemulsion-based pluronic-lecithin organogel for the management of arthritic pain. Micro Nanosyst. 2024 16 1 36 45 10.2174/0118764029280588231215044630
[Google Scholar]